Best Business Newspaper

Global Injectable Drug Delivery Market is Anticipated to Reach USD 931.1 Billion by 2024

Orbis Research
OrbisResearch.com has published new research report on “Global Injectable Drug Delivery Market Analysis, By Device Type (Self-injection Devices, Conventional Devices), By Formulation (Conventional Drug Delivery, Novel Drug Delivery), By Therapeutic Use (Autoimmune Disorders, Hormonal Disorders, Oncology), By End-user Application (Hospitals, Homecare Settings, Research Institutes, Clinical Laboratories), By Region And Segment Forecasts From 2013 to 2024” to its database.

The global injectable drug delivery market is expected to reach USD 931.1 billion by 2024, according to a new report by Grand View Research, Inc. The increase in number of chronic diseases like diabetes and cancer has fueled the need for injectable drug delivery. Unlike other traditional forms of drug delivery, injectables allow maximum bioavailability of the pharmaceutical drug as it bypasses the first pass metabolism. With substantial growth in technological advancements, the devices being manufactured and marketed are built so as to cater to the specific needs of the patients.

Browse the report: http://www.orbisresearch.com/reports/index/injectable-drug-delivery-market-analysis-by-device-type-formulation-formulation-end-user-application-user-application-and-segment-forecasts-from-2013-to-2024

With the advent of self-injection devices, injectable drugs can be self administered without the need of medical assistance. A large number of technology-oriented developments have taken place in the biologics market, which further increases the applicability of these injectable devices in the challenging disease areas. Self-injection devices have allowed patients suffering from diabetes to manage insulin levels with auto-injectors, pen-injectors, and needle-free injectors; thus, the homecare segment has been a large grosser in the end-user application.

The major restraints in this market are injuries and infections caused by needles, ambiguities related to regulatory reimbursements, sterility of the injectable drugs, and the preference of other drug delivery systems that possess less toxicity and are easy to administer. Despite these restraints, the market potential for injectable drug delivery products is tremendous with majority of the key players opting to injectables over other forms of delivery. The injectable drug delivery industry, based on product type is segmented into two sub-types namely self-injection devices and conventional injection devices. Further, on the basis of therapeutic use, the injectable drug delivery industry is segmented into autoimmune disorders, hormonal disorders, oncology, and others.

Request a sample of the report: http://www.orbisresearch.com/contacts/request-sample/112779

The injectable drug delivery industry by end-user application is categorized into hospitals, homecare settings, and others including research establishments, diagnostics, and clinical laboratories.

Further key findings from the study suggest:

North America is expected to lead the market for injectable drug delivery devices with the largest number of patients suffering from chronic diseases like diabetes and cancer along with autoimmune disorders. The reason why countries in North America are leading is due to the technological innovations and advanced research in the area that enable them to excel at designing new and improved drug delivery products.

Buy the [email protected]http://www.orbisresearch.com/contact/purchase/112779

The Asia Pacific market is set to lead exceptionally well owing to the partnerships with other well established global players. This region has also witnessed enormous investments in research and development; thus, accelerating the growth of the injectables market in this region.

The homecare settings has been the most profit garnering segment with a large cohort of patients suffering from chronic diseases and hence the resultant high utility of these devices at a primary level for better control and management of the disease.

Some key market players include Pfizer, Inc., Schott AG, Becton, Dickinson and Company, Baxter International, Inc., and ELI Lilly & Co.

Major points From table Of Contents:

Chapter One: Methodology and Scope

Chapter Two: Executive Summary

Chapter Three: Injectable Drug DeliveryIndustry Outlook

Chapter Four: Injectable Drug Delivery Product Type Outlook

Chapter Five: Injectable Drug Delivery Therapeutic Use Outlook

Chapter Six: Injectable Drug Delivery End-User Application Outlook

Chapter Seven: Injectable Drug Delivery Regional Outlook

Chapter Eight: Competitive Landscape

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Media Contact
Company Name: Orbis Research
Contact Person: Hector Costello
Email: Send Email
Phone: +1 (214) 884-6817
Address:4144N Central Expressway, Suite 600
City: Dallas
State: Texas
Country: United States
Website: http://www.orbisresearch.com/reports/index/injectable-drug-delivery-market-analysis-by-device-type-formulation-formulation-end-user-application-user-application-and-segment-forecasts-from-2013-to-2024